Regulators of g-protein signaling in the heart and their potential as therapeutic targets

Circulation Research

Volumn 109, Issue 3, 2011, Pages 320-333

  Zhang, Peng ^a   Mende, Ulrike ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

cardiac fibroblasts; cardiac myocytes; myocardium; RGS proteins; signal transduction

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; REGULATOR OF G PROTEIN SIGNALING 5; REGULATOR OF G PROTEIN SIGNALING 6; RGS PROTEIN; RGS2 PROTEIN; RGS4 PROTEIN; UNCLASSIFIED DRUG;

CANONICAL ANALYSIS; CELLULAR DISTRIBUTION; GENE EXPRESSION; HEART; HEART RATE VARIABILITY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; GTP-BINDING PROTEINS; HEART DISEASES; HUMANS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 79961071456     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.231423     Document Type: Review

References (149)

1. Salazar NC, Chen J, Rockman HA. Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta. 2007;1768:1006-1018. (Pubitemid 46463942)
2. q and acceleration is inhibited by Gβγ subunits. J Biol Chem. 1999;274:19639-19643.
3. Ross EM, Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem. 2000;69:795-827.
4. i subfamily of G protein α subunits. Cell. 1996;86:445-452. (Pubitemid 26272084)
5. iα1: stabilization of the transition state for GTP hydrolysis. Cell. 1997;89:251-261. (Pubitemid 27199897)
6. Soundararajan M, Willard FS, Kimple AJ, Turnbull AP, Ball LJ, Schoch GA, Gileadi C, Fedorov OY, Dowler EF, Higman VA, Hutsell SQ, Sundstrom M, Doyle DA, Siderovski D. P. Structural diversity in the RGS domain and its interaction with heterotrimeric G protein α-subunits. Proc Natl Acad Sci USA. 2008;105:6457-6462. (Pubitemid 351758367)
7. q-mediated signaling. J Biol Chem. 2004;276:3906-3915. (Pubitemid 38198973)
8. Tesmer JJ. Structure and Function of Regulator of G Protein Signaling Homology Domains. Vol 86. Amsterdam, The Netherlands: Elsevier; 2009.
9. Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev. 2002;54:527-559.
10. Gu S, Cifelli C, Wang S, Heximer SP. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci (Lond). 2009;116:391-399.
11. Manzur M, Ganss R. Regulator of G protein signaling 5: a new player in vascular remodeling. Trends Cardiovasc Med. 2009;19:26-30.
12. Anderson GR, Posokhova E, Martemyanov KA. The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling. Cell Biochem Biophys. 2009;54:33-46.
13. Traynor J. Regulator of G protein-signaling proteins and addictive drugs. Ann N Y Acad Sci. 2010;1187:341-352.
14. Druey KM. Regulation of G-protein-coupled signaling pathways in allergic inflammation. Immunol Res. 2009;43:62-76.
15. Hurst JH, Hooks SB. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem Pharmacol. 2009;78:1289-1297.
16. Mittmann C, Chung CH, Hoppner G, Michalek C, Nose M, Schuler C, Schuh A, Eschenhagen T, Weil J, Pieske B, Hirt S, Wieland T. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res. 2002;55:778-786.
17. Wieland T, Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther. 2003;97:95-115. (Pubitemid 36136081)
18. Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res. 2005;96:401-411. (Pubitemid 40354533)
19. Doupnik CA, Xu T, Shinaman JM. Profile of RGS expression in single rat atrial myocytes. Biochim Biophys Acta. 2001;1522:97-107. (Pubitemid 34028210)
20. Kardestuncer T, Wu H, Lim AL, Neer EJ. Cardiac myocytes express mRNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria. FEBS Lett. 1998;438:285-288. (Pubitemid 28529290)
21. Zhang P, Su J, King ME, Maldonado AE, Park C, Mende U. Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses. Am J Physiol Heart Circ Physiol. April 15, 2011 [Epub ahead of print].
22. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res. 2004;122:24-34. (Pubitemid 38264544)
23. Grillet N, Pattyn A, Contet C, Kieffer BL, Goridis C, Brunet JF. Generation and characterization of Rgs4 mutant mice. Mol Cell Biol. 2005;25:4221-4228. (Pubitemid 40617667)
24. Cifelli C, Rose RA, Zhang H, Voigtlaender-Bolz J, Bolz SS, Backx PH, Heximer SP. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ Res. 2008;103:527-535.
25. Xie Y, Wolff DW, Wei T, Wang B, Deng C, Kirui JK, Jiang H, Qin J, Abel PW, Tu Y. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res. 2009;69:5743-5751.
26. q/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J Biol Chem. 2006;281:5811-5820. (Pubitemid 43853012)
27. Klaiber M, Kruse M, Volker K, Schroter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londono JE, Baba HA, Abramowitz J, Birnbaumer L, Penninger JM, Pongs O, Kuhn M. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. Basic Res Cardiol. 2010;105:583-595.
28. Heximer SP, Srinivasa SP, Bernstein LS, Bernard JL, Linder ME, Hepler JR, Blumer KJ. G protein selectivity is a determinant of RGS2 function. J Biol Chem. 1999;274:34253-34259. (Pubitemid 129511765)
29. Kimple AJ, Soundararajan M, Hutsell SQ, Roos AK, Urban DJ, Setola V, Temple BR, Roth BL, Knapp S, Willard FS, Siderovski DP. Structural determinants of G-protein α subunit selectivity by regulator of G-protein signaling 2 (RGS2). J Biol Chem. 2009;284:19402-19411.
30. Hao J, Michalek C, Zhang W, Zhu M, Xu X, Mende U. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation. J Mol Cell Cardiol. 2006;41:51-61. (Pubitemid 44172945)
31. Ingi T, Krumins AM, Chidiac P, Brothers GM, Chung S, Snow BE, Barnes CA, Lanahan AA, Siderovski DP, Ross EM, Gilman AG, Worley PF. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J Neurosci. 1998;18:7178-7188. (Pubitemid 28425805)
32. i. Mol Pharmacol. 2002;62:654-659. (Pubitemid 36329384)
33. Chen C, Zheng B, Han J, Lin SC. Characterization of a novel mammalian RGS protein that binds to Gα proteins and inhibits pheromone signaling in yeast. J Biol Chem. 1997;272:8679-8685. (Pubitemid 27147835)
34. q α function. Proc Natl Acad Sci USA. 1997;94:14389-14393.
35. i signaling. J Mol Cell Cardiol. 2011;50:1000-1007.
36. Salim S, Sinnarajah S, Kehrl JH, Dessauer CW. Identification of RGS2 and type V adenylyl cyclase interaction sites. J Biol Chem. 2003;278:15842-15849. (Pubitemid 36799699)
37. Sinnarajah S, Dessauer CW, Srikumar D, Chen J, Yuen J, Yilma S, Dennis JC, Morrison EE, Vodyanoy V, Kehrl JH. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature. 2001;409:1051-1055. (Pubitemid 32204058)
38. s and adenylyl cyclase in living cells. Cell Signal. 2006;18:336-348. (Pubitemid 41661349)
39. Nunn C, Zou MX, Sobiesiak AJ, Roy AA, Kirshenbaum LA, Chidiac P. RGS2 inhibits β-adrenergic receptor-induced cardiomyocyte hypertrophy. Cell Signal. 2010;22:1231-1239.
40. 2- induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation. J Biol Chem. 2001;276:24293-24300.
41. i-coupled receptors from Rac1 to RhoA activation. Cell Signal. 2007;19:1229-1237. (Pubitemid 46561560)
42. Yau DM, Sethakorn N, Taurin S, Kregel S, Sandbo N, Camoretti-Mercado B, Sperling AI, Dulin NO. Regulation of Smad-mediated gene transcription by RGS3. Mol Pharmacol. 2008;73:1356-1361. (Pubitemid 351574825)
43. Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol. 2008;9:73-80. (Pubitemid 350286206)
44. Liang G, Bansal G, Xie Z, Druey KM. RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J Biol Chem. 2009;284:21719-21727.
45. Oudit GY, Penninger JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res. 2009;82:250-260.
46. Xie Z, Geiger TR, Johnson EN, Nyborg JK, Druey KM. RGS13 acts as a nuclear repressor of CREB. Mol Cell. 2008;31:660-670.
47. i family G-proteins with differential selectivity and maximal activity. J Biol Chem. 2003;278:10087-10093. (Pubitemid 36800265)
48. 5. Proc Natl Acad Sci USA. 2003;100:6604-6609. (Pubitemid 36666628)
49. 5-RGS9 complex. Nat Struct Mol Biol. 2008;15:155-162. (Pubitemid 351227317)
50. Jayaraman M, Zhou H, Jia L, Cain MD, Blumer KJ. R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling. Trends Pharmacol Sci. 2009;30:17-24.
51. Burgon PG, Lee WL, Nixon AB, Peralta EG, Casey PJ. Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). J Biol Chem. 2001;276:32828-32834.
52. i interaction sites with guanine nucleotide dissociation inhibitor activity. J Biol Chem. 2001;276:29275-29281.
53. Willard MD, Willard FS, Li X, Cappell SD, Snider WD, Siderovski DP. Selective role for RGS12 as a Ras/Raf/MEK scaffold in nerve growth factor-mediated differentiation. EMBO J. 2007;26:2029-2040. (Pubitemid 46625794)
54. Willard FS, Willard MD, Kimple AJ, Soundararajan M, Oestreich EA, Li X, Sowa NA, Kimple RJ, Doyle DA, der CJ, Zylka MJ, Snider WD, Siderovski DP. Regulator of G-protein signaling 14 (RGS14) is a selective H-Ras effector. PLoS One. 2009;4:e4884.
55. Shu FJ, Ramineni S, Hepler JR. RGS14 is a multifunctional scaffold that integrates G protein and Ras/Raf MAPkinase signalling pathways. Cell Signal. 2010;22:366-376.
56. Nunn C, Mao H, Chidiac P, Albert PR. RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling. Semin Cell Dev Biol. 2006;17:390-399. (Pubitemid 44066849)
57. Abramow-Newerly M, Roy AA, Nunn C, Chidiac P. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal. 2006;18:579-591. (Pubitemid 43113289)
58. q signaling. J Biol Chem. 2004;279:26314-26322. (Pubitemid 38798781)
59. s and sorting nexin in vesicular trafficking. Science. 2001;294:1939-1942. (Pubitemid 33101593)
60. 12/13-mediated signaling pathways. Neurosignals. 2009;17:55-70.
61. Gu S, Anton A, Salim S, Blumer KJ, Dessauer CW, Heximer SP. Alternative translation initiation of human regulators of G-protein signaling-2 yields a set of functionally distinct proteins. Mol Pharmacol. 2008;73:1-11. (Pubitemid 350294191)
62. Wolff DW, Xie Y, Deng C, Gatalica Z, Yang M, Wang B, Wang J, Lin MF, Abel PW, Tu Y. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. Int J Cancer. April 15, 2011 [Epub ahead of print].
63. q and PLC-β protein abundance in cardiac hypertrophy and failure. Am J Physiol. 1999;277:H2298- H2304. (Pubitemid 30048150)
64. Zhang S, Watson N, Zahner J, Rottman JN, Blumer KJ, Muslin AJ. RGS3 and RGS4 are GTPase activating proteins in the heart. J Mol Cell Cardiol. 1998;30:269-276. (Pubitemid 28116306)
65. i2 in acutely failing donor hearts and end-stage heart failure. Eur Heart J. 2001;22:1015-1020. (Pubitemid 32737563)
66. Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol. 2008;585:278-291.
67. 1- adrenergic activation in cultured ventricular myocytes. Cell Signal. 2006;18:1655-1663.
68. Kehrl JH, Sinnarajah S. RGS2: a multifunctional regulator of G-protein signaling. Int J Biochem Cell Biol. 2002;34:432-438. (Pubitemid 34242757)
69. Tsang S, Woo AY, Zhu W, Xiao RP. Deregulation of RGS2 in cardiovascular diseases. Front Biosci (Schol Ed). 2010;2:547-557.
70. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn ME, Kass DA. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest. 2009;119:408-420.
71. Xie Z, Yang Z, Druey KM. Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation. J Mol Cell Biol. 2010;2:357-365.
72. Derrien A, Zheng B, Osterhout JL, Ma YC, Milligan G, Farquhar MG, Druey KM. Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability. J Biol Chem. 2003;278:16107-16116. (Pubitemid 36799732)
73. Sjoegren B, Neubig RR. Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling. Mol Pharmacol. 2010;78:550-557.
74. Davydov IV, Varshavsky A. RGS4 is arginylated and degraded by the N-end rule pathway in vitro. J Biol Chem. 2000;275:22931-22941. (Pubitemid 30646180)
75. Lee MJ, Tasaki T, Moroi K, An JY, Kimura S, Davydov IV, Kwon YT. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc Natl Acad Sci USA. 2005;102:15030-15035. (Pubitemid 41513329)
76. Wang J, Xie Y, Wolff DW, Abel PW, Tu Y. DHHC protein-dependent palmitoylation protects regulator of G-protein signaling 4 from proteasome degradation. FEBS Lett. 2010;584:4570-4574.
77. Yang J, Kamide K, Kokubo Y, Takiuchi S, Tanaka C, Banno M, Miwa Y, Yoshii M, Horio T, Okayama A, Tomoike H, Kawano Y, Miyata T. Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens. 2005;23:1497-1505. (Pubitemid 41104821)
78. Bodenstein J, Sunahara RK, Neubig RR. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol. 2007;71:1040-1050. (Pubitemid 46457008)
79. Pedram A, Razandi M, Kehrl J, Levin ER. Natriuretic peptides inhibit G protein activation: mediation through cross-talk between cyclic GMP-dependent protein kinase and regulator of G protein signaling proteins. J Biol Chem. 2000;275:7365-7372. (Pubitemid 30146290)
80. 11 signaling. J Biol Chem. 2001;276:5438-5444.
81. Tang M, Wang G, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med. 2003;9:1506-1512. (Pubitemid 38004778)
82. Jones TL. Role of palmitoylation in RGS protein function. Methods Enzymol. 2004;389:33-55. (Pubitemid 39119060)
83. o. Mol Pharmacol. 2005;67:132-139. (Pubitemid 40069973)
84. Hiol A, Davey PC, Osterhout JL, Waheed AA, Fischer ER, Chen CK, Milligan G, Druey KM, Jones TL. Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function, I: mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. J Biol Chem. 2003;278:19301-19308. (Pubitemid 36799323)
85. i subunits. Proc Natl Acad Sci USA. 1996;93:15203-15208.
86. q-mediated signaling. J Biol Chem. 1999;274:18836-18842.
87. Castro-Fernandez C, Janovick JA, Brothers SP, Fisher RA, Ji TH, Conn PM. Regulation of RGS3 and RGS10 palmitoylation by GnRH. Endocrinology. 2002;143:1310-1317. (Pubitemid 34279368)
88. Chidiac P, Roy AA. Activity, regulation, and intracellular localization of RGS proteins. Receptors Channels. 2003;9:135-147. (Pubitemid 36874789)
89. Sethakorn N, Yau DM, Dulin NO. Non-canonical functions of RGS proteins. Cell Signal. 2010;22:1274-1281.
90. Roy AA, Lemberg KE, Chidiac P. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol Pharmacol. 2003;64:587-593. (Pubitemid 37048561)
91. Liu Z, Fisher RA. RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity. J Biol Chem. 2004;279:14120-14128. (Pubitemid 38468948)
92. Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve LR, Ethier N, Trieu P, Allen BG, Hebert TE. Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res. 2006;71:69-78. (Pubitemid 43849672)
93. 1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res. 2008;103:992-1000.
94. Gobeil F, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M, Heveker N, Bkaily G, Chemtob S, Barbaz D. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol. 2006;84:287-297. (Pubitemid 44481092)
95. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens. 2008;17:168-173. (Pubitemid 351253042)
96. Heximer SP, Blumer KJ. RGS proteins: Swiss army knives in seventransmembrane domain receptor signaling networks. Sci STKE. 2007;370:pe2.
97. Neitzel KL, Hepler JR. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling. Semin Cell Dev Biol. 2006;17:383-389. (Pubitemid 44066843)
98. Wang Q, Liu M, Mullah B, Siderovski DP, Neubig RR. Receptorselective effects of endogenous RGS3 and RGS5 to regulate mitogenactivated protein kinase activation in rat vascular smooth muscle cells. J Biol Chem. 2002;277:24949-24958. (Pubitemid 34951796)
99. Niu J, Scheschonka A, Druey KM, Davis A, Reed E, Kolenko V, Bodnar R, Voyno-Yasenetskaya T, Du X, Kehrl J, Dulin NO. RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain. Biochem J. 2002;365:677-684. (Pubitemid 34864449)
100. 2+/Calmodulin reverses phosphatidylinositol 3, 4, 5-trisphosphate-dependent inhibition of regulators of G protein-signaling GTPase-activating protein activity. J Biol Chem. 2000;275:18962-18968. (Pubitemid 30422861)
101. i oscillations. Mol Cell. 2001;7:651-660. (Pubitemid 32706356)
102. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev. 2010;90:291-366.
103. Nguyen CH, Ming H, Zhao P, Hugendubler L, Gros R, Kimball SR, Chidiac P. Translational control by RGS2. J Cell Biol. 2009;186:755-765.
104. Jin Y, Zhong H, Omnaas JR, Neubig RR, Mosberg HI. Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors. J Pept Res. 2004;63:141-146. (Pubitemid 38333842)
105. 11. Mol Cell Biol. 1999;19:714-723. (Pubitemid 29018472)
106. 1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem. 1998;273:12794-12797. (Pubitemid 28246834)
107. Fu Y, Zhong H, Nanamori M, Mortensen RM, Huang X, Lan K, Neubig RR. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins. Methods Enzymol. 2004;389:229-243. (Pubitemid 39119071)
108. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, Kelly DP, Muslin AJ. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest. 1999;104:567-576.
109. q overexpressing mice. J Mol Cell Cardiol. 2001;33:209-218. (Pubitemid 32537921)
110. Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira-dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, Wyss JM, Mecham RP, Blumer KJ. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest. 2003;111:445-452. (Pubitemid 36228001)
111. Gross V, Tank J, Obst M, Plehm R, Blumer KJ, Diedrich A, Jordan J, Luft FC. Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1134-R1142. (Pubitemid 40593696)
112. Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z, Bai X, Zhou H, Jiang H, Heximer SP, Qin M, Huang H, Liu PP, Huang C. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci USA. 2010;107:13818-13823.
113. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol. 2005;45:657-687. (Pubitemid 40261821)
114. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation. 2000;101:1130-1137. (Pubitemid 30146614)
115. A receptor in cultured human cardiac fibroblasts. Cell Physiol Biochem. 2004;14:285-292. (Pubitemid 39179197)
116. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009;123:255-278.
117. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest. 2010;120:254-265.
118. Fu Y, Huang X, Zhong H, Mortensen RM, D'Alecy LG, Neubig RR. Endogenous RGS proteins and Gα subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. Circ Res. 2006;98:659-666.
119. Fu Y, Huang X, Piao L, Lopatin AN, Neubig RR. Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. Am J Physiol Heart Circ Physiol. 2007;292:H2532-H2539. (Pubitemid 47084638)
120. KACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Circ Res. 2010;107:1350-1354.
121. Yang J, Huang J, Maity B, Gao Z, Lorca RA, Gudmundsson H, Li J, Stewart A, Swaminathan PD, Ibeawuchi SR, Shepherd A, Chen CK, Kutschke W, Mohler PJ, Mohapatra DP, Anderson ME, Fisher RA. RGS6, a modulator of parasympathetic activation in heart. Circ Res. 2010;107:1345-1349.
122. Tuomi JM, Chidiac P, Jones DL. Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. Am J Physiol Heart Circ Physiol. 2009;298:H554-H561.
123. i2-mediated protection from ischemic injury is modulated by endogenous RGS proteins in the mouse heart. Cardiovasc Res. March 23, 2011 [Epub ahead of print].
124. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63:1256-1272. (Pubitemid 36627220)
125. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727-730. (Pubitemid 37361545)
126. Tang CM, Insel PA. GPCR expression in the heart: "new" receptors in myocytes and fibroblasts. Trends Cardiovasc Med. 2004;14:94-99. (Pubitemid 38569675)
127. Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev. 2005;85:1159-1204. (Pubitemid 41362268)
128. Kamal FA, Smrcka AV, Blaxall BC. Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits. J Mol Cell Cardiol. January 21, 2011 [Epub ahead of print].
129. Semplicini A, Lenzini L, Sartori M, Papparella I, Calo LA, Pagnin E, Strapazzon G, Benna C, Costa R, Avogaro A, Ceolotto G, Pessina AC. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens. 2006;24:1115-1124. (Pubitemid 43772320)
130. Calo LA, Pagnin E, Davis PA, Sartori M, Ceolotto G, Pessina AC, Semplicini A. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome: a role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab. 2004;89:4153-4157. (Pubitemid 39071528)
131. Young KH, Wang Y, Bender C, Ajit S, Ramirez F, Gilbert A, Nieuwenhuijsen BW. Yeast-based screening for inhibitors of RGS proteins. Methods Enzymol. 2004;389:277-301. (Pubitemid 39119074)
132. Roman DL, Talbot JN, Roof RA, Sunahara RK, Traynor JR, Neubig RR. Identification of small-molecule inhibitors of RGS4 using a highthroughput flow cytometry protein interaction assay. Mol Pharmacol. 2007;71:169-175. (Pubitemid 46020986)
133. Wang Y, Lee Y, Zhang J, Young KH. Identification of peptides that inhibit regulator of G protein signaling 4 function. Pharmacology. 2008;82:97-104.
134. Sjoegren B, Blazer LL, Neubig RR. Regulators of G protein signaling proteins as targets for drug discovery. Prog Mol Biol Transl Sci. 2010;91:81-119.
135. Zhong H, Neubig RR. Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther. 2001;297:837-845. (Pubitemid 32472477)
136. Roman DL, Blazer LL, Monroy CA, Neubig RR. Allosteric inhibition of the regulator of G protein signaling-Gα protein-protein interaction by CCG-4986. Mol Pharmacol. 2010;78:360-365.
137. Blazer LL, Roman DL, Chung A, Larsen MJ, Greedy BM, Husbands SM, Neubig RR. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol. 2011;78:524-533.
138. 2+/calmodulin competitively bind to the regulators of G-protein-signalling (RGS) domain of RGS4 and reciprocally regulate its action. Biochem J. 2005;385:65-73.
139. Zheng B, De Vries L, Gist Farquhar M. Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies. Trends Biochem Sci. 1999;24:411-414. (Pubitemid 29528196)
140. von Buchholtz L, Elischer A, Tareilus E, Gouka R, Kaiser C, Breer H, Conzelmann S. RGS21 is a novel regulator of G protein signalling selectively expressed in subpopulations of taste bud cells. Eur J Neurosci. 2004;19:1535-1544. (Pubitemid 38437916)
141. Li X, Chen L, Ji C, Liu B, Gu J, Xu J, Zou X, Gu S, Mao Y. Isolation and expression pattern of RGS21 gene, a novel RGS member. Acta Biochim Pol. 2005;52:943-946. (Pubitemid 43155028)
142. Harris IS, Treskov I, Rowley MW, Heximer S, Kaltenbronn K, Finck BN, Gross RW, Kelly DP, Blumer KJ, Muslin AJ. G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes. 2004. 2004;53:3082-3090. (Pubitemid 39564482)
143. Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M, Nakao K, Kangawa K. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation. 2008;117:2329-2339. (Pubitemid 351653552)
144. Nisancioglu MH, Mahoney WM Jr, Kimmel DD, Schwartz SM, Betsholtz C, Genove G. Generation and characterization of rgs5 mutant mice. Mol Cell Biol. 2008;28:2324-2331. (Pubitemid 351429978)
145. Cho H, Park C, Hwang IY, Han SB, Schimel D, Despres D, Kehrl JH. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol. 2008;28:2590-2597. (Pubitemid 351542360)
146. Huang X, Fu Y, Charbeneau RA, Saunders TL, Taylor DK, Hankenson KD, Russell MW, D'Alecy LG, Neubig RR. Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol. 2006;26:6870-6879. (Pubitemid 44387636)
147. Blumer JB, Smrcka AV, Lanier SM. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Therapeut. 2007;113:488-506. (Pubitemid 46389413)
148. Noor N, Patel CB, Rockman HA. β-Arrestin: a signaling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol. November 11, 2010 [Epub ahead of print].
149. i protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA. 2003;100:16077-16082. (Pubitemid 38021117)